# ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients

> **NCT00396461** · PHASE4 · TERMINATED · sponsor: **B. Braun Medical SA** · enrollment: 212 (estimated)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** MCT/LCT (1:1)
- **DRUG:** MCT/LCT/omega-3 (5:4:1)

## Key facts

- **NCT ID:** NCT00396461
- **Lead sponsor:** B. Braun Medical SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2010-09
- **Final completion:** 2011-02
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2013-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396461, "ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00396461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*